Ambrx Biopharma Cayman, Inc. Quarterly Assets in USD from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Ambrx Biopharma Cayman, Inc. quarterly Assets history and growth rate from Q4 2020 to Q2 2023.
Ambrx Biopharma Cayman, Inc. Assets for the quarter ending June 30, 2023 was $280M, a 54.8% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$280M	+$99.1M	+54.8%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$211M			Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$147M	-$82M	-35.8%	Dec 31, 2022	10-Q	2023-08-09
Q2 2022	$181M			Jun 30, 2022	6-K	2022-08-29
Q4 2021	$229M	+$95M	+70.9%	Dec 31, 2021	10-K	2023-03-30
Q4 2020	$134M			Dec 31, 2020	20-F	2022-04-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.